脫鈣骨基質市場規模、佔有率和成長分析：按產品類型、組織來源、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球脫礦骨基質 (DBM) 市場價值為 13.3 億美元，預計到 2033 年將從 2025 年的 14.2 億美元成長至 23.6 億美元，預測期（2026-2033 年）複合年成長率為 6.6%。

全球脫礦骨基質（DBM）市場正經歷顯著成長，這主要歸功於其在整形外科和牙科治療中促進骨再生方面發揮的關鍵作用。隨著脊椎融合手術手術需求的不斷成長，外科醫生越來越傾向於使用DBM，因為它能夠最大限度地減少自體骨移植相關的併發症。技術進步，特別是加工方法的改進，提高了DBM的安全性和有效性，進一步增強了其臨床意義。人口老化和骨質疏鬆性骨折病例的增加，推動了醫療系統對DBM的需求，促使其尋求高效的替代療法。人工智慧驅動的自動化技術的出現提高了生產效率和品質一致性，使製造商能夠快速回應市場需求並降低營運成本。因此，高品質骨移植材料的供應正在加速成長。

全球去礦骨基質市場的成長要素

全球整形外科和創傷手術數量的不斷成長，使得骨移植替代材料的需求持續強勁。這促使醫療機構和外科醫生擴大使用脫礦骨基質（DBM）作為自體骨移植的有效替代方案。這一趨勢的驅動力在於脫礦骨基質能夠促進骨骼自然癒合，並最大限度地減少手術部位併發症，最終加快患者康復。因此，醫療專業人員正逐步將DBM產品應用於外科手術實務中，推動了已開發市場和新興市場等不同醫療環境下的市場成長。此外，DBM已確立的安全性也進一步加速了其在複雜重組手術中的應用，從而促進了整體市場擴張。

全球去礦骨基質（DBM）市場的限制因素

由於不同地區對生物移植產品的法律規範存在差異，全球脫礦骨基質（DBM）市場面臨嚴峻挑戰。製造商必須應對複雜的文件編制、臨床檢驗流程和合規要求，這可能導致核准時間延長和研發成本增加。這種複雜性阻礙了中小企業進入市場，導致可供選擇的DBM產品種類有限。此外，某些地區嚴格的安全標準可能會阻礙這些產品的推廣應用，即使臨床需求旺盛，也會限制市場成長。另外，廣泛的上市後監測需求也增加了企業營運的負擔，延緩了創新解決方案的推廣應用，最終阻礙了市場成長。

全球去礦骨基質市場趨勢

在全球脫礦骨基質市場，個人化同種異體移植解決方案正呈現出顯著的成長趨勢，而精準醫療的進步正是推動這一趨勢的關鍵因素。隨著個人化治療方案在醫療保健領域的重要性日益凸顯，針對患者基因譜和特定缺損部位特徵量身定做的脫礦骨基質配方需求也日益成長。這一趨勢促使製造商致力於開發先進的加工技術和生物標記分析方法，從而提高移植成功率、減少併發症並縮短患者康復時間。因此，個人化解決方案正成為整形外科和脊椎重組領域市場成長的重要驅動力，最終將提升臨床醫生和患者對不同醫療保健系統中生物療法的信心。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 宏觀經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球去礦骨基質市場規模：依產品類型分類

• 油灰
• 凝膠
• 貼上
• 纖維
  • 脫鈣皮質纖維
  • 互鎖纖維基體
• 海綿
• 條狀和片狀
• 其他

全球去礦骨基質市場規模：依組織來源分類

• 用於種子移植的皮質骨
• 用於同種異體移植的鬆質骨
• 同種異體移植與合成材料的聯合應用
• 其他

全球脫礦骨基質市場規模：按應用領域分類

• 脊椎固定
• 牙科手術
• 關節重組
• 創傷性骨折的處理
• 足踝重組
• 顱顎顏面外科
• 其他

全球脫礦骨基質市場規模：依最終用戶分類

• 醫院
• 專業整形外科診所
• 牙醫診所
• 門診手術中心
• 其他

全球脫礦骨基質市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zimmer Biomet Holdings, Inc.
• Orthofix Medical Inc.
• Stryker Corporation
• Medtronic plc
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Holdings Corporation
• Enovis Corporation
• Baxter International Inc.
• MTF Biologics
• AlloSource
• Community Tissue Services
• Xtant Medical Holdings, Inc.
• LifeNet Health
• Biocomposites Ltd.
• Straumann Holding AG
• Arthrex, Inc.
• Globus Medical, Inc.
• Tissue Regenix Group plc
• RTI Surgical, Inc.
• Berkeley Advanced Biomaterials, Inc.

結論與建議

Global Demineralized Bone Matrix Market size was valued at USD 1.33 Billion in 2024 and is poised to grow from USD 1.42 Billion in 2025 to USD 2.36 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).

The global market for demineralized bone matrix (DBM) is experiencing significant growth, primarily driven by its vital role in accelerating bone regeneration in orthopedic and dental procedures. Increasing demand for spinal fusion surgeries is prompting surgeons to prefer DBM due to its effectiveness in minimizing complications associated with autograft harvesting. Technological advancements, particularly in processing methods, have improved the safety and potency of DBM, reinforcing its clinical significance. The aging population, coupled with a rise in osteoporotic fractures, further galvanizes demand as healthcare systems seek efficient treatment alternatives. The emergence of AI-driven automation enhances production efficiency and consistency, enabling manufacturers to respond swiftly to market needs and reduce operational costs, ultimately accelerating the supply of high-quality bone grafts to healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Demineralized Bone Matrix market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Demineralized Bone Matrix Market Segments Analysis

Global demineralized bone matrix market is segmented by product type, tissue source, application, end user and region. Based on product type, the market is segmented into Putty, Gel, Paste, Fiber, Sponge, Strips and Sheets and Others. Based on tissue source, the market is segmented into Allograft Cortical Bone, Allograft Cancellous Bone, Combined Allograft and Synthetics and Others. Based on application, the market is segmented into Spinal Fusion, Dental Procedures, Joint Reconstruction, Trauma Fracture Management, Foot and Ankle Reconstruction, Craniomaxillofacial Surgery and Others. Based on end user, the market is segmented into Hospitals, Specialty Orthopedic Clinics, Dental Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Demineralized Bone Matrix Market

The increasing prevalence of orthopedic and trauma surgeries globally generates a consistent demand for bone graft substitutes, leading healthcare providers and surgeons to increasingly utilize demineralized bone matrix as a viable alternative to autografts. This trend is fueled by the matrix's capacity to promote natural bone healing and minimize complications associated with donor site harvesting, ultimately facilitating improved patient recovery. As a result, healthcare professionals are progressively integrating DBM products into their surgical practices, driving market growth across a variety of healthcare environments, both in developed nations and emerging markets. Moreover, the established safety profile of DBM further incentivizes its adoption for intricate reconstruction procedures, contributing to the overall expansion of the market.

Restraints in the Global Demineralized Bone Matrix Market

The global Demineralized Bone Matrix (DBM) market faces significant challenges due to the diverse regulatory frameworks surrounding biologic grafts in different regions. Manufacturers must navigate complex documentation, clinical validation processes, and compliance requirements, which can extend approval times and inflate development costs. This complexity tends to deter smaller companies from entering the market, resulting in a restricted range of DBM products available. Moreover, stringent safety standards in certain areas may hinder the adoption rates of these products, limiting market growth despite strong clinical demand. Additionally, the necessity for extensive post-marketing surveillance further burdens operations and slows the introduction of innovative solutions, ultimately stifling market growth.

Market Trends of the Global Demineralized Bone Matrix Market

The Global Demineralized Bone Matrix market is experiencing a significant trend towards personalized allograft solutions driven by advancements in precision medicine. As healthcare increasingly emphasizes individualized treatment approaches, there is growing demand for customized demineralized bone matrix formulations that align with patients' genetic profiles and specific defect characteristics. This trend encourages manufacturers to focus on developing advanced processing techniques and biomarker analytics, leading to improved graft integration rates, minimize complications, and enhance patient recovery times. Consequently, personalized solutions are becoming essential catalysts for market growth in orthopedic and spinal reconstruction, ultimately fostering heightened clinician-patient trust in biologic therapies across diverse healthcare systems.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Demineralized Bone Matrix Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Putty
• Gel
• Paste
• Fiber
  • Demineralized Cortical Fibers
  • Interlocking Fiber Matrix
• Sponge
• Strips and Sheets
• Others

Global Demineralized Bone Matrix Market Size by Tissue Source & CAGR (2026-2033)

• Market Overview
• Allograft Cortical Bone
• Allograft Cancellous Bone
• Combined Allograft and Synthetics
• Others

Global Demineralized Bone Matrix Market Size by Application & CAGR (2026-2033)

• Market Overview
• Spinal Fusion
• Dental Procedures
• Joint Reconstruction
• Trauma Fracture Management
• Foot and Ankle Reconstruction
• Craniomaxillofacial Surgery
• Others

Global Demineralized Bone Matrix Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Orthopedic Clinics
• Dental Clinics
• Ambulatory Surgical Centers
• Others

Global Demineralized Bone Matrix Market Size & CAGR (2026-2033)

• North America (Product Type, Tissue Source, Application, End User)
  • US
  • Canada
• Europe (Product Type, Tissue Source, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Tissue Source, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Tissue Source, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Tissue Source, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enovis Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTF Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlloSource
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Community Tissue Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeNet Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocomposites Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Straumann Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berkeley Advanced Biomaterials, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations